Coupling of α1-Adrenoceptors to ERK1/2 in the Human Prostate
Authors:
- Frank StrittmatterFSFrank Strittmatter
- Christian GratzkeCGChristian Gratzke
- Johanna GöttingerJGJohanna Göttinger
- Boris SchlenkerBSBoris Schlenker
- Oliver ReichOROliver Reich
- Christian G. StiefCSChristian G. Stief
- Petter HedlundPHPetter Hedlund
- Karl-Erik AnderssonKAKarl-Erik Andersson
- Martin HennenbergMHMartin Hennenberg
- 3 February 2011
- journal article
- research article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 86 (4) , 427-433
Abstract
Introduction: α1-Adrenoceptors are considered critical for the regulation of prostatic smooth muscle tone. However, previous studies suggested further α1-adrenoceptor functions besides contraction. Here, we investigated whether α1-adrenoceptors in the human prostate may activate extracellular signal-regulated kinases (ERK1/2). Methods: Prostate tissues from patients undergoing radical prostatectomy were stimulated in vitro. Activation of ERK1/2 was assessed by Western blot analysis. Expression of ERK1/2 was studied by immunohistochemistry. The effect of ERK1/2 inhibition by U0126 on phenylephrine-induced contraction was studied in organ-bath experiments. Results: Stimulation of human prostate tissue with noradrenaline (30 µM) or phenylephrine (10 µM) resulted in ERK activation. This was reflected by increased levels of phosphorylated ERK1/2. Expression of ERK1/2 in the prostate was observed in smooth muscle cells. Incubation of prostate tissue with U0126 (30 µM) resulted in ERK1/2 inhibition. Dose-dependent phenylephrine-induced contraction of prostate tissue was not modulated by U0126. Conclusions: α1-Adrenoceptors in the human prostate are coupled to ERK1/2. This may partially explain previous observations suggesting a role of α1-adrenoceptors in the regulation of prostate growth.Keywords
This publication has 28 references indexed in Scilit:
- α1‐Adrenoceptor subtypes and lower urinary tract symptomsInternational Journal of Urology, 2008
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostateProstate Cancer and Prostatic Diseases, 2006
- α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostateBritish Journal of Pharmacology, 2006
- Norepinephrine activates P44 and P42 MAPK in human prostate stromal and smooth muscle cells but not in epithelial cellsThe Prostate, 2003
- Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in miceThe Prostate, 2002
- Apoptotic and Proliferative Index after Alpha-1-Adrenoceptor Antagonist and/or Finasteride Treatment in Benign Prostatic HyperplasiaUrologia Internationalis, 2002
- MEK1/2–ERK1/2 Mediates α1-Adrenergic Receptor-stimulated Hypertrophy in Adult Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 2001
- alpha 1-ADRENOCEPTOR ANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1999
- INDUCTION OF PROSTATE APOPTOSIS BY DOXAZOSIN IN BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1998